,Molecular targeted therapy of gynecological malignant tumors: the development and challenge, from l

来源 :中国高等学校学术文摘·医学 | 被引量 : 0次 | 上传用户:awaydown
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
More and more molecular drugs based on targeted therapy have been utilized in the treatment of gynecologic cancer, especially in ovarian cancer. In this article, we systematically review the current targeted therapeutic trials running in clinic. Large, randomized trials have been conducted in the treatment of ovarian cancer, endometrial cancer and cervical cancer by using small molecule, antisense, mutational gene as well as antibodies. Other planned or ongoing trials currently targeted at molecular markers which may play important roles in gynecological carcinogenesis and progression suggest that combination chemotherapy with molecular targeted therapy will ultimately be an important option.
其他文献
Stressing the uniqueness and complexity of traditional Chinese medicine (TCM) theory system,this paper analyzes the characteristics of TCM as a discipline from
It has been demonstrated that β-elemene could protect against carbon tetrachloride (CCl4)-induced liver fibrosis in our laboratory work, and the aim of this pa
The superiority of the cumulative outcomes of day 5/6 embryo transfer to those of day 2/3 embryo transfer in infertile couples has been debated.This retrospecti
The aim of this study was to determine the prevalence of overweight and obese subjects in the Shanghai population of China and its association with undiagnosed
The gradual development of Chinese medicine is based on constant accumulation and summary of experience in clinical practice,but without the benefit of undergoi
Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML).The prognosis of APL has changed from the worst among the AMLs to current
To examine whether the activation of brainstem neurons during intake of a sweet tastant is due to orosensory signals or post-ingestive factors,we compared the d